Market By Application, Component, And Country | Forecast 2021-2028
Triton’s research report established that the precision medicine market in the Middle East and Africa is expected to observe growth at a compound annual growth rate of 8.37% through the estimated years of 2021-2028.
The countries considered for analysis in this market are:
• The United Arab Emirates
• Turkey
• South Africa
• Saudi Arabia
• Rest of Middle East & Africa
In Middle East and Africa, genetic diseases are highly prevalent than other diseases. This increases the need for an advanced healthcare system to understand the mechanisms of these genetic conditions. Along with this, the international collaboration programs to aid early screening, diagnosis, and treatment based on the patient’s DNA would fuel the adoption of precision medicines. Hence, such factors are estimated to propel the precision medicine market on a positive growth trajectory in the Middle East and Africa region.
Saudi Arabia, for instance, holds high potential to become the leading nation in precision medicine innovations. The studied market’s growth is primarily motivated by the high incidence of genetic diseases, in addition to the growing healthcare costs. Also, the ever-increasing support from the government through investments in research projects to improve the treatment of various chronic conditions influences the advancement of precision medicine technologies. Thus, the surge in government funding, paired with increasing genetic diseases, is fueling Saudi Arabia’s precision medicine market progression.
Furthermore, the UAE precision medicine market is still in its nascent stage, but is likely to gain momentum over the next few years. There is a substantial rise in the occurrence of chronic diseases, resulting in high healthcare costs. This is one of the major factors expected to open several new opportunities for the precision medicine market in the United Arab Emirates.
F Hoffmann-La Roche AG is a healthcare company involved in developing and marketing innovative therapeutic and diagnostic products. Also, it researches and manufactures pharmaceutical products for various fields, including immunology, infectious diseases, and neuroscience. The company provides its products to laboratories, hospitals, researchers, and healthcare professionals in multiple regions, including the Middle East and Africa.
1. MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. KEY INSIGHTS
2.1.1. PRESENCE OF BIOPHARMACEUTICAL COMPANIES
2.1.2. INVESTMENTS IN GENE THERAPY
2.2. IMPACT OF COVID-19 ON PRECISION MEDICINE MARKET
2.3. SUPPLY CHAIN OUTLOOK
2.4. ETYMOLOGY OF PRECISION MEDICINE
2.5. PORTER’S FIVE FORCES MODEL
2.6. MARKET ATTRACTIVENESS INDEX
2.7. VENDOR LANDSCAPE
2.8. KEY MARKET STRATEGIES
2.8.1. CONTRACTS AND PARTNERSHIPS
2.8.2. BUSINESS EXPANSION & DIVESTITURES
2.8.3. ACQUISITIONS & MERGERS
2.8.4. NEW PRODUCT LAUNCHES
2.9. MARKET DRIVERS
2.9.1. HIGH PREVALENCE OF CHRONIC DISEASES IN THE AGING POPULATION
2.9.2. DIGITAL COLLABORATION AMONG RESEARCH GROUPS AND ORGANIZATIONS
2.9.3. IDENTIFICATION OF GENETIC MAKEUP IN THE HUMAN GENOME
2.10. MARKET CHALLENGES
2.10.1. STRINGENT DRUG APPROVAL PROCESS
2.10.2. SECURITY THREATS PERTAINING TO DATA SHARING
2.10.3. CHANGES IN REIMBURSEMENT AND REGULATORY PROCESS
2.11. MARKET OPPORTUNITIES
2.11.1. INVESTMENTS BY GOVERNMENT AND PRIVATE PLAYERS IN CANCER TREATMENT
2.11.2. DEMAND FOR PREVENTIVE CARE
3. MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET - BY APPLICATION
3.1. ONCOLOGY
3.2. INFECTIOUS DISEASES
3.3. NEUROLOGY/PHYSIATRY
3.4. CARDIOVASCULAR
3.5. LIFESTYLE AND ENDOCRINOLOGY
3.6. GASTROENTEROLOGY
3.7. OTHER APPLICATIONS
4. MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET - BY COMPONENT
4.1. APPLIED SCIENCE
4.1.1. GENOMICS
4.1.1.1. PCR
4.1.1.2. PM NGS
4.1.1.3. GENOME EDITING
4.1.1.4. OTHER GENOMICS TECHNOLOGIES
4.1.2. PHARMACOGENOMICS
4.1.3. OTHER APPLIED SCIENCES
4.2. PRECISION THERAPEUTICS
4.2.1. CLINICAL TRIALS
4.2.2. CELL THERAPY
4.2.3. DRUG DISCOVERY AND RESEARCH
4.2.4. GENE THERAPY
4.3. PRECISION DIAGNOSTICS
4.3.1. MOLECULAR DIAGNOSTICS
4.3.1.1. NON-INVASIVE PRENATAL TESTING (NIPT)
4.3.1.2. COMPANION DIAGNOSTICS
4.3.1.3. LIQUID BIOPSY
4.3.1.4. OTHER MOLECULAR DIAGNOSTICS
4.3.2. MEDICAL IMAGING
4.3.2.1. IMAGING ANALYTICS
4.3.2.2. IMAGING COMPUTER-AIDED DETECTION (CADX)
4.4. DIGITAL HEALTH AND INFORMATION TECHNOLOGY
4.4.1. CLINICAL DECISION SUPPORT SYSTEMS (CDSS)
4.4.2. BIG DATA ANALYTICS
4.4.3. IT INFRASTRUCTURE
4.4.4. GENOMICS INFORMATICS
4.4.5. IN-SILICO INFORMATICS
4.4.6. MOBILE HEALTH
5. MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET – REGIONAL OUTLOOK
5.1. COUNTRY ANALYSIS
5.1.1. SAUDI ARABIA
5.1.2. UNITED ARAB EMIRATES
5.1.3. TURKEY
5.1.4. SOUTH AFRICA
5.1.5. REST OF MIDDLE EAST & AFRICA
6. COMPETITIVE LANDSCAPE
6.1. ABBOTT LABORATORIES
6.2. ASTRAZENECA PLC
6.3. BIOCRATES LIFE SCIENCES AG
6.4. BIO-RAD LABORATORIES INC
6.5. DANAHER CORPORATION
6.6. EAGLE GENOMICS LTD
6.7. ELI LILLY & COMPANY
6.8. F HOFFMANN-LA ROCHE AG
6.9. INTOMICS
6.10. LABORATORY CORPORATION OF AMERICA HOLDINGS
6.11. NANOSTRING TECHNOLOGIES
6.12. NOVARTIS AG
6.13. PFIZER INC
6.14. QIAGEN NV
6.15. QUEST DIAGNOSTICS INCORPORATED
7. RESEARCH METHODOLOGY & SCOPE
7.1. RESEARCH SCOPE & DELIVERABLES
7.1.1.  OBJECTIVES OF STUDY
7.1.2.  SCOPE OF STUDY
7.2. SOURCES OF DATA
7.2.1.  PRIMARY DATA SOURCES
7.2.2.  SECONDARY DATA SOURCES
7.3. RESEARCH METHODOLOGY
7.3.1.  EVALUATION OF PROPOSED MARKET
7.3.2.  IDENTIFICATION OF DATA SOURCES
7.3.3.  ASSESSMENT OF MARKET DETERMINANTS
7.3.4.  DATA COLLECTION
7.3.5.  DATA VALIDATION & ANALYSIS
TABLE 1:Â Â Â Â Â Â MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2:Â Â Â Â Â Â MARKET ATTRACTIVENESS INDEX
TABLE 3:Â Â Â Â Â Â VENDOR LANDSCAPE
TABLE 4:Â Â Â Â Â Â LIST OF CONTRACTS & PARTNERSHIPS
TABLE 5:Â Â Â Â Â Â LIST OF BUSINESS EXPANSIONS & DIVESTITURES
TABLE 6:Â Â Â Â Â Â LIST OF ACQUISITIONS & MERGERS
TABLE 7:Â Â Â Â Â Â LIST OF NEW PRODUCT LAUNCHES
TABLE 8:Â Â Â Â Â Â MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 9:Â Â Â Â Â Â MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET, BY COMPONENT, 2021-2028 (IN $ MILLION)
TABLE 10:Â Â Â Â MIDDLE EAST AND AFRICA APPLIED SCIENCE MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 11:Â Â Â Â MIDDLE EAST AND AFRICA GENOMICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 12:Â Â Â Â MIDDLE EAST AND AFRICA PRECISION THERAPEUTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 13:Â Â Â Â MIDDLE EAST AND AFRICA PRECISION DIAGNOSTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 14:Â Â Â Â MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 15:Â Â Â Â MIDDLE EAST AND AFRICA MEDICAL IMAGING MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 16:Â Â Â Â MIDDLE EAST AND AFRICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 17:Â Â Â Â MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1:Â Â Â Â MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 2:Â Â Â Â MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET, BY APPLICATION, 2020 & 2028
FIGURE 3:Â Â Â Â MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET, BY ONCOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 4:Â Â Â Â MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET, BY INFECTIOUS DISEASES, 2021-2028 (IN $ MILLION)
FIGURE 5:Â Â Â Â MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET, BY NEUROLOGY/PHYSIATRY, 2021-2028 (IN $ MILLION)
FIGURE 6:Â Â Â Â MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET, BY CARDIOVASCULAR, 2021-2028 (IN $ MILLION)
FIGURE 7:Â Â Â Â MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET, BY LIFESTYLE AND ENDOCRINOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 8:Â Â Â Â MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET, BY GASTROENTEROLOGY, 2021-2028 (IN $ MILLION)
FIGURE 9:Â Â Â Â MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 10:Â MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET, BY COMPONENT, 2020 & 2028
FIGURE 11:Â MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET, BY APPLIED SCIENCE, 2021-2028 (IN $ MILLION)
FIGURE 12:Â MIDDLE EAST AND AFRICA APPLIED SCIENCE MARKET, BY GENOMICS, 2021-2028 (IN $ MILLION)
FIGURE 13:Â MIDDLE EAST AND AFRICA GENOMICS MARKET, BY PCR, 2021-2028 (IN $ MILLION)
FIGURE 14:Â MIDDLE EAST AND AFRICA GENOMICS MARKET, BY PM NGS, 2021-2028 (IN $ MILLION)
FIGURE 15:Â MIDDLE EAST AND AFRICA GENOMICS MARKET, GENOME EDITING, 2021-2028 (IN $ MILLION)
FIGURE 16:Â MIDDLE EAST AND AFRICA GENOMICS MARKET, BY OTHER GENOMICS TECHNOLOGIES, 2021-2028 (IN $ MILLION)
FIGURE 17:Â MIDDLE EAST AND AFRICA APPLIED SCIENCE MARKET, BY PHARMACOGENOMICS, 2021-2028 (IN $ MILLION)
FIGURE 18:Â BIOMARKERS ROLE IN PHARMACOGENOMICS
FIGURE 19:Â MIDDLE EAST AND AFRICA APPLIED SCIENCE MARKET, BY OTHER APPLIED SCIENCES, 2021-2028 (IN $ MILLION)
FIGURE 20:Â MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET, BY PRECISION THERAPEUTICS, 2021-2028 (IN $ MILLION)
FIGURE 21:Â MIDDLE EAST AND AFRICA PRECISION THERAPEUTICS MARKET, BY CLINICAL TRIALS, 2021-2028 (IN $ MILLION)
FIGURE 22:Â MIDDLE EAST AND AFRICA PRECISION THERAPEUTICS MARKET, BY CELL THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 23:Â MIDDLE EAST AND AFRICA PRECISION THERAPEUTICS MARKET, BY DRUG DISCOVERY AND RESEARCH, 2021-2028 (IN $ MILLION)
FIGURE 24:Â MIDDLE EAST AND AFRICA PRECISION THERAPEUTICS MARKET, BY GENE THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 25:Â MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET, BY PRECISION DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 26:Â MIDDLE EAST AND AFRICA PRECISION DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 27:Â MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY NON-INVASIVE PRENATAL TESTING (NIPT), 2021-2028 (IN $ MILLION)
FIGURE 28:Â MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY COMPANION DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 29:Â MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY LIQUID BIOPSY, 2021-2028 (IN $ MILLION)
FIGURE 30:Â MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY OTHER MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 31:Â MIDDLE EAST AND AFRICA PRECISION DIAGNOSTICS MARKET, BY MEDICAL IMAGING, 2021-2028 (IN $ MILLION)
FIGURE 32:Â MIDDLE EAST AND AFRICA MEDICAL IMAGING MARKET, BY IMAGING ANALYTICS, 2021-2028 (IN $ MILLION)
FIGURE 33:Â MIDDLE EAST AND AFRICA MEDICAL IMAGING MARKET, BY IMAGING COMPUTER-AIDED DETECTION (CADX), 2021-2028 (IN $ MILLION)
FIGURE 34:Â MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET, BY DIGITAL HEALTH AND INFORMATION TECHNOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 35:Â MIDDLE EAST AND AFRICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY CLINICAL DECISION SUPPORT SYSTEMS (CDSS), 2021-2028 (IN $ MILLION)
FIGURE 36:Â MIDDLE EAST AND AFRICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY BIG DATA ANALYTICS, 2021-2028 (IN $ MILLION)
FIGURE 37:Â MIDDLE EAST AND AFRICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY IT INFRASTRUCTURE, 2021-2028 (IN $ MILLION)
FIGURE 38:Â MIDDLE EAST AND AFRICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY GENOMICS INFORMATICS, 2021-2028 (IN $ MILLION)
FIGURE 39:Â MIDDLE EAST AND AFRICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY IN-SILICO INFORMATICS, 2021-2028 (IN $ MILLION)
FIGURE 40:Â MIDDLE EAST AND AFRICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY MOBILE HEALTH, 2021-2028 (IN $ MILLION)
FIGURE 41:Â SAUDI ARABIA PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 42:Â UNITED ARAB EMIRATES PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 43:Â TURKEY PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 44:Â SOUTH AFRICA PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 45:Â REST OF MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)